ESC 365 - Levosimendan, milrinone and dobutamine in acute experimental pulmonary embolism.

ACVC Premium Access

Levosimendan, milrinone and dobutamine in acute experimental pulmonary embolism.

Session: Young Investigators Award session

Topic: Pharmacotherapy

Speaker: Doctor M. Lyhne (Horsens, DK)

Event: ACVC 2021

Congress Presentation

Add to my library

About the speaker

Doctor Mads Dam Lyhne

Horsens Hospital, Horsens (Denmark)

0 follower

4 more presentations in this session

Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support versus intra-aortic balloon pump in severe cardiogenic shock.

Speaker: Ms M. Karami (Amsterdam, NL)

Systolic blood pressure and outcome in patients admitted with acute heart failure: a pooled analysis from 4 randomized clinical trials.

Speaker: Doctor J. Grand (Copenhagen, DK)

Inflammation and neurohormonal activation is increased at hospital admission in patients with ST-elevation myocardial infarction with diabetes compared to non-diabetic patients.

Speaker: Unknown J. Kunkel (Copenhagen, DK)

Time to awakening tendency and withdrawal of life supporting treatment (WLST) in patients treated with therapeutic hypothermia after cardiac arrest.

Speaker: Miss M. Rivadeneira Ruiz (Madrid, ES)

Access the full session

Young Investigators Award session

Speakers: Doctor M. Lyhne, Ms M. Karami, Doctor J. Grand, Unknown J. Kunkel, Miss M. Rivadeneira Ruiz

About the event

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources